From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. Summary and Comment

Does HDL Matter When Statins Are Working?

In a post hoc analysis of TNT trial data, HDL levels predicted cardiovascular events in patients with very low LDL levels.

Little information is available about risk for cardiovascular events in patients who are treated aggressively with statins. In particular, does HDL retain its strong prognostic value in patients with very low LDL levels? To find out, investigators from the Treating to New Targets (TNT) trial, in which 2661 participants achieved LDL cholesterol levels below 70 mg/dl (Journal Watch Cardiology Dec 30 2005), analyzed post hoc the relationship between HDL cholesterol levels and major cardiovascular events.

A total of 9770 study patients (age range, 35 to 75) with clinically evident coronary artery disease were stratified by quintile of HDL cholesterol level at 3 months of statin treatment. In multivariable analysis, HDL quintile at month 3 was a strong and significant predictor of cardiovascular events. Patients in the highest quintile (≥55 mg/dL) had a 25% lower risk for cardiovascular events than those in the lowest quintile (<38 mg/dL). This relationship was independent of statin dose or LDL level. The ratio of LDL cholesterol to HDL cholesterol at 3 months was also strongly and significantly predictive of cardiovascular events. Subjects with the lowest LDL:HDL ratios (<1.33) experienced fewer than half as many events as those with the highest ratios (≥2.41).

Comment: HDL cholesterol levels have prognostic importance even in patients in whom aggressive statin treatment has achieved low LDL cholesterol levels. Clinicians should remain alert to all known cardiovascular risk factors when using statins to treat patients with coronary artery disease.

Harlan M. Krumholz, MD, SM

Published in Journal Watch Cardiology September 26, 2007

Citation(s):

Barter P et al. for the Treating to New Targets Investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007 Sep 27; 357:1301.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Related Content

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.